| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 03/02/2022 | Elicio Therapeutics, Inc. | ANGN | Grant | Stock Option (Right to Buy) | 175k | $1.99 | $348.2k | | 03/02/2022 |
| 03/02/2022 | Elicio Therapeutics, Inc. | ANGN | Grant | Stock Option (Right to Buy) | 100k | $1.99 | $199k | | 03/02/2022 |
| 12/14/2021 | Elicio Therapeutics, Inc. | ANGN | Sale | Common Stock | 451 | $2.42 | $1.1k | | 12/14/2021 |
| 11/15/2021 | Elicio Therapeutics, Inc. | ANGN | Sale | Common Stock | 433 | $4.40 | $1.9k | | 11/15/2021 |
| 10/14/2021 | Elicio Therapeutics, Inc. | ANGN | Sale | Common Stock | 430 | $8.65 | $3.7k | | 10/14/2021 |
| 09/14/2021 | Elicio Therapeutics, Inc. | ANGN | Sale | Common Stock | 430 | $10.64 | $4.6k | | 09/14/2021 |
| 08/16/2021 | Elicio Therapeutics, Inc. | ANGN | Sale | Common Stock | 445 | $10.68 | $4.8k | | 08/16/2021 |
| 07/21/2021 | Elicio Therapeutics, Inc. | ANGN | Sale | Common Stock | 432 | $10.94 | $4.7k | | 07/21/2021 |
| 07/14/2021 | Elicio Therapeutics, Inc. | ANGN | Sale | Common Stock | 431 | $11.01 | $4.7k | | 07/14/2021 |
| 06/14/2021 | Elicio Therapeutics, Inc. | ANGN | Sale | Common Stock | 427 | $13.27 | $5.7k | | 06/14/2021 |
| 05/14/2021 | Elicio Therapeutics, Inc. | ANGN | Sale | Common Stock | 440 | $13.92 | $6.1k | | 05/14/2021 |
| 04/15/2021 | Elicio Therapeutics, Inc. | ANGN | Sale | Common Stock | 399 | $15.01 | $6k | | 04/15/2021 |
| 03/13/2021 | Elicio Therapeutics, Inc. | ANGN | Sale | Common Stock | 499 | $20.45 | $10.2k | | 03/13/2021 |
| 02/13/2021 | Elicio Therapeutics, Inc. | ANGN | Sale | Common Stock | 457 | $19.54 | $8.9k | | 02/13/2021 |
| 02/04/2021 | Elicio Therapeutics, Inc. | ANGN | Grant | Stock Option (Right to Buy) | 70k | $16.00 | $1.1M | | 02/04/2021 |
| 06/20/2019 | Adamas Pharmaceuticals Inc | ADMS | Sale | Common Stock | 940 | $5.35 | $5k | | 06/20/2019 |
| 04/08/2019 | Adamas Pharmaceuticals Inc | ADMS | Grant | Stock Option (Right to Buy) | 60k | $6.81 | $408.6k | | 04/08/2019 |
| 04/08/2019 | Adamas Pharmaceuticals Inc | ADMS | Grant | Common Stock | 30k | $0.00 | $0 | | 04/08/2019 |
| 03/20/2019 | Adamas Pharmaceuticals Inc | ADMS | Sale | Common Stock | 1.8k | $7.99 | $14.3k | | 03/20/2019 |
| 12/20/2018 | Adamas Pharmaceuticals Inc | ADMS | Sale | Common Stock | 425 | $7.52 | $3.2k | | 12/20/2018 |
| 06/21/2018 | Adamas Pharmaceuticals Inc | ADMS | Sale | Common Stock | 1k | $25.48 | $25.5k | | 06/21/2018 |
| 03/21/2018 | Adamas Pharmaceuticals Inc | ADMS | Sale | Common Stock | 982 | $25.89 | $25.4k | | 03/21/2018 |
| 03/06/2018 | Adamas Pharmaceuticals Inc | ADMS | Grant | Stock Option (Right to Buy) | 37.5k | $25.66 | $962.2k | | 03/06/2018 |
| 03/06/2018 | Adamas Pharmaceuticals Inc | ADMS | Grant | Common Stock | 6.2k | $0.00 | $0 | | 03/06/2018 |
| 12/21/2017 | Adamas Pharmaceuticals Inc | ADMS | Sale | Common Stock | 440 | $32.30 | $14.2k | | 12/21/2017 |
| 06/21/2017 | Adamas Pharmaceuticals Inc | ADMS | Sale | Common Stock | 1k | $17.53 | $18.3k | | 06/21/2017 |
| 01/18/2017 | Adamas Pharmaceuticals Inc | ADMS | Grant | Common Stock | 11.2k | $0.00 | $0 | | 01/18/2017 |
| 01/18/2017 | Adamas Pharmaceuticals Inc | ADMS | Grant | Stock Option (Right to Buy) | 67.5k | $16.61 | $1.1M | | 01/18/2017 |
| 11/07/2016 | Adamas Pharmaceuticals Inc | ADMS | Grant | Common Stock | 4.7k | $0.00 | $0 | | 11/07/2016 |
| 11/07/2016 | Adamas Pharmaceuticals Inc | ADMS | Grant | Stock Option (Right to Buy) | 28.1k | $14.26 | $401.1k | | 11/07/2016 |
| 05/06/2016 | Adamas Pharmaceuticals Inc | ADMS | Grant | Common Stock | 11.2k | $0.00 | $0 | | 05/06/2016 |
| 05/06/2016 | Adamas Pharmaceuticals Inc | ADMS | Grant | Stock Option (Right to Buy) | 67.5k | $14.70 | $992.2k | | 05/06/2016 |